News & Media
Press Center & More

Up-to-date press releases and statements in all categories, as well as materials for journalists.

Nov 29, 2022

World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 Vaccine as a Primary Series in Adolescents and as a Booster in Adults

Nov 23, 2022

Termination of COVID-19 Vaccine Purchase Agreement with Gavi

Nov 18, 2022

Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults

Media contact

Images, videos, and files for media use

Extensive materials for members of the press, including broadcast, online, film, radio and print journalists.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.